The role of HIPEC in the complex treatment of patients with peritonealy-disiminated cancer of the stomach

Mashukov, A. O.; Maksimovsky, V. E.; Yarema, R. R.; Tkachenko, O. I.

dc.contributor.author	Mashukov, A. O.	en
dc.contributor.author	Maksimovsky, V. E.	en
dc.contributor.author	Yarema, R. R.	en
dc.contributor.author	Tkachenko, O. I.	en
dc.date.accessioned	2021-03-30T05:39:35Z
dc.date.available	2021-03-30T05:39:35Z
dc.date.issued	2019
dc.identifier.citation	The role of HIPEC in the complex treatment of patients with peritonealy-disiminated cancer of the stomach / A. O. Mashukov, V. E. Maksimovsky, R. R. Yarema, O. I. Tkachenko // Фундаментальна медицина: інтегральні підходи до терапії хворих з онкопатологією: наук.-практ. конф. молодих вчених, 4–5 лютого 2019 р., Київ: тези. – Київ, 2019. – С. 78.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/9090
dc.description.abstract	The combination of gastrectomy (GE), peritoneoectomy (PE) and hyperthermic chemoperfusion (HIPEC) with gastric cancer (GC) is part of a specific medical ideology that has been implemented by a group of enthusiasts united under PSOGI (Peritoneal Surface Oncology Group International – the global medical community for the study of peritoneal carcinomatosis). The aim. Considering the controversialities of world experience in the use of HIPEC (the results vary from extremely positive to rather negative), it was necessary to study the survival of patients with carcinomatosis using standard chemotherapy and HIPEC.	en
dc.language.iso	en	en
dc.subject	HIPEC	en
dc.subject	carcinomatosis	en
dc.subject	standard chemotherapy	en
dc.subject	survival of patients	en
dc.title	The role of HIPEC in the complex treatment of patients with peritonealy-disiminated cancer of the stomach	en
dc.type	Article	en